missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ACMSD Monoclonal Antibody (3A9)

Description
Peptide Sequence: SHGFSMRPDL CAQDNPMNPK KYLGSFYTDA LVHDPLSLKL LTDVIGKDKV ILGTDYPFPL GELEPGKLIE SMEEFDEETK NKLKAGNALA FLGLERKQFE.
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase; EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM, Oct 2004].
Specifications
Specifications
| Antigen | ACMSD |
| Applications | ELISA, Western Blot |
| Classification | Monoclonal |
| Clone | 3A9 |
| Concentration | 0.2-1.0 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene | ACMSD |
| Gene Accession No. | Q8TDX5 |
| Gene Alias | 2-amino-3-carboxylmuconate-6-semialdehyde decarboxylase; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; Acmsd; amino carboxymuconate semialdehyde decarboxylase; aminocarboxymuconate semialdehyde decarboxylase; Picolinate carboxylase; zgc:162888 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?